Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Finland Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20131
20141
20151
20161
20171
20182
20191
20203
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Turku University Hospital7
Tampere University Hospital3
Hoffmann-La Roche2
BioCis Pharma Ltd1
Bristol-Myers Squibb1
Eli Lilly and Company1
Medical Research Council1
Nektar Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms17
Carcinoma, Transitional Cell4
Recurrence3
Neoplasm Metastasis2
Colorectal Neoplasms, Hereditary Nonpolyposis1
Neoplastic Syndromes, Hereditary1
Non-Muscle Invasive Bladder Neoplasms1
Postoperative Nausea and Vomiting1
Postoperative Pain1
Urethral Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.